Radioresistance can be identified through clinical observations of treatment outcomes, as well as laboratory techniques. Tumor biopsies and molecular profiling can reveal genetic and epigenetic markers associated with resistance. Functional assays may also be used to assess the DNA repair capabilities of cancer cells.
